Cabazitaxel – Solvated & Amorphous
Cabazitaxel is a semi-synthetic taxane antineoplastic API (CAS 183133-96-2) offered in Solvated (1:1 acetone solvatomorph) and Amorphous forms. Indicated in combination with prednisone for metastatic castration-resistant prostate cancer (mCRPC).
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Formulation & Industry Applications
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: